STEPHANIE FARMER: Open Payments
NPI 1295202927 · DANIELSON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 56 payments from 18 companies in 2025. Trend: 2023 $1,412 · 2024 $1,723 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $254 |
| Phathom Pharmaceuticals, Inc. | 6 | $135 |
| Novo Nordisk Inc | 5 | $97 |
| Vanda Pharmaceuticals Inc. | 4 | $94 |
| GlaxoSmithKline, LLC. | 3 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| Indivior Inc. | 1 | $39 |
| PFIZER INC. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $35 |
| Merck Sharp & Dohme LLC | 2 | $33 |
Products named: VOQUEZNA, QULIPTA, FANAPT, TRELEGY ELLIPTA, VRAYLAR, Ozempic, UBRELVY, REXULTI.
Industry payments across CT — which companies pay providers there.
